Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SYNB1020 in hepatic insufficiency and cirrhosis
NCT03447730Phase 2Terminated
- Sponsor
- Synlogic
- Start
- Mar 2018
- Primary completion
- Jul 2019
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
A Phase 2 trial of SYNB1020 in hyperammonemia, sponsored by Synlogic. Started Mar 2018; status: terminated.
02
Drugs
SYNB1020
03
Conditions
hyperammonemia
Beyond the preview
Go deeper on NCT03447730.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03447730.